Sentiment · EMR
Lobbying Spend for EMR
AI-generated plain-English read of lobbying spend for EMR. Updated daily.
Light lobbying, stable
highLight, stable lobbying. The company has a minimal but persistent DC presence, not a signal driver at this level.
What will probably happen
- Stable spend means no new urgency. Existing policy relationships are being maintained; no imminent legislative inflection is signaled.
- Spend is spread across many issue areas: the company has diverse regulatory exposure and is fighting on multiple fronts simultaneously.
What to do
- If you HOLD this stock
- This lobbying read is structural, not a timing signal. Hold as planned; revisit if trajectory changes next quarter.
- If you're EVALUATING this stock
- No sharp lobbying signal to factor into entry timing. Evaluate on fundamentals.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
55 quarters of history with $1.75M in total spend: sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Light
- Trajectory
- Stable
- Issue concentration
- Broad
- Registrant base
- Diversified
- Last quarter
- $50.0K
- Last 4Q total
- $200.0K
- Prior 4Q total
- $200.0K
- Quarters on record
- 55
- Unique issue areas
- 8
- Unique registrants
- 6
- Top issue area
- TAXATION/INTERNAL REVENUE CODE (38% of spend)
- Top registrant
- AKIN GUMP STRAUSS HAUER & FELD (38% of spend)
Key levels
| Level | Value |
|---|---|
| last quarter amount | 50,000 |
| last 4q total | 200,000 |
| prior 4q total | 200,000 |
| total amount | 1,750,000 |
| top issue pct | 0.377 |
| top registrant pct | 0.383 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.